Radioimmunotherapy: is avidin-biotin pretargeting the preferred choice among pretargeting methods?
Paganelli
Giovanni
G
Nuclear Medicine Division, European Institute of Oncology, via Ripamonti 435, 20141, Milan, Italy. direzione.mnu@ieo.it
Chinol
Marco
M
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D001360:Avidin / Q000627:therapeutic use*; D001710:Biotin / Q000627:therapeutic use*; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D009369:Neoplasms / Q000532:radiotherapy*; D016499:Radioimmunotherapy / Q000379:methods*; D011878:Radiotherapy / Q000379:methods*
D000911:Antibodies, Monoclonal; D001360:Avidin; D001710:Biotin